LY-2090314 Uses, Dosage, Side Effects and more
Ly2090314 has been used in trials studying the treatment of Leukemia, Advanced Cancer, and Pancreatic Cancer.
| Attribute | Details |
|---|---|
| Trade Name | LY-2090314 |
| Generic | LY-2090314 |
| Type | |
| Formula | C28H25FN6O3 |
| Weight | Average: 512.545 Monoisotopic: 512.197216852 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
